Overview

Detailed Summary

Astec LifeSciences Ltd is primarily engaged in the manufacturing of agrochemicals and pharmaceutical intermediates, offering active ingredients, intermediates, and formulations mainly for crop protection and API manufacturers.
The company expanded its operations significantly over the years, reaching an installed production capacity of 3150 MT, as of FY 2009-10. This expansion included acquiring new plots and establishing multiple manufacturing units.
Astec LifeSciences has built strategic relationships with major multinationals like Syngenta and Nufarm, indicating strong integration into the global agrochemical supply chain.
In 2015, Godrej Agrovet Limited acquired a major stake in the company, making Astec LifeSciences a subsidiary, which led to enhanced investment and growth opportunities.
Recently, the company has focused on innovation, inaugurating the Adi Godrej Centre for Chemical Research and Development in 2023, indicating a drive towards advanced R&D capabilities.

Sector: Fertilizers & Agrochemicals
Industry: Pesticides & Agrochemicals
Market Cap: 1,478 Cr
Volatility: Moderate Risk
P/E Ratio: 0.0
Industry P/E: 22.2
PEG Ratio: —
P/B Ratio: 3.8
52W High: 936.00
52W Low: 512.35

Sales CAGR

1Y: 17.53%
3Y: -10.65%
5Y: -4.18%
10Y: 4.08%

Profit CAGR

1Y: 39.96%
3Y: —
5Y: —
10Y: —

ROE

TTM: -20.72%
3Y: -26.38%
5Y: -8.12%
10Y: 1.92%

ROCE

TTM: -5.54%
3Y: -12.20%
5Y: -0.06%
10Y: 9.69%

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BHARATRAS		1263.20	2,098 Cr	13.12	1.65	0.04	11.43	15.51	10.17
INSECTICID		618.60	1,796 Cr	12.96	1.47	0.32	11.42	14.78	6.97
IPL		149.90	1,726 Cr	14.39	1.71	0.50	11.86	15.46	8.96
ASTEC		662.75	1,469 Cr	—	3.76	0.00	-20.72	-5.54	-8.59
PUNJABCHEM		1130.45	1,386 Cr	21.20	3.27	0.27	15.10	17.43	7.77
MOL		54.44	1,384 Cr	48.18	0.90	0.00	1.86	6.75	0.95
DHARMAJ		260.50	882 Cr	16.13	1.96	0.00	12.17	15.44	6.50
Median: 7 Co.	—	618.60	1,469 Cr	15.26	1.71	0.04	11.43	15.44	6.97

Financial Statements

Upcoming Result Date: Jul 30, 2026

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	51	154	69	99	94	120	91	74	125	159
Expenses	69	141	116	118	100	114	102	80	121	149
Operating Profit	-18	13	-46	-20	-5.74	5.53	-11	-6.69	3.99	9.16
OPM %	-36.11	8.27	-66.67	-20.02	-6.12	4.63	-12.07	-9.07	3.20	5.77
Other Income	0.91	2.05	0.92	2.00	1.91	0.79	0.51	1.12	-1.27	2.63
Interest	6.09	6.67	7.04	9.33	9.92	10	11	8.40	7.17	7.92
Depreciation	8.70	9.01	9.27	11	11	12	11	10	11	12
Profit Before Tax	-32	-0.93	-62	-39	-25	-16	-33	-24	-16	-7.90
Tax %	24.49	-4.30	35.56	-0.03	-60.52	-2.68	-0.03	-0.04	-0.06	1.90
Net Profit	-24	-0.96	-40	-39	-40	-16	-33	-24	-16	-7.75
EPS in Rs	-10.92	-0.44	-17.83	-17.30	-18.12	-7.22	-14.83	-11.35	-7.04	-3.48

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	313	371	431	523	555	677	628	458	381	448
Expenses	236	299	354	437	443	522	552	464	448	453
Operating Profit	77	72	76	85	112	154	76	-5.91	-66	-4.53
OPM %	24.61	19.43	17.75	16.30	20.10	22.77	12.14	-1.29	-17.36	-1.01
Other Income	-7.74	12	11	12	7.92	10	13	5.64	5.63	2.98
Interest	12	11	12	13	4.75	9.06	21	25	37	35
Depreciation	14	15	19	23	26	34	34	36	44	45
Profit Before Tax	29	56	56	61	89	121	35	-62	-141	-81
Tax %	33.28	37.11	36.02	22.53	26.95	25.79	26.76	24.06	4.45	0.15
Net Profit	19	35	36	48	65	90	26	-47	-135	-81
EPS in Rs	8.56	15.69	15.42	22.31	29.18	40.30	11.47	-21.07	-60.47	-36.70
Dividend Payout %	15.34	8.41	8.21	6.18	4.52	3.27	11.50	-6.27	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	20	20	20	20	20	20	20	20	20	22
Reserves	119	150	183	227	290	377	400	350	215	368
Borrowings	126	124	176	99	187	279	341	494	555	449
Other Liabilities	69	119	83	226	181	221	219	112	92	103
Total Liabilities	334	413	461	572	678	897	979	975	881	942
Fixed Assets	103	115	167	194	213	340	318	386	499	459
CWIP	7.56	42	19	24	116	23	127	165	21	20
Investments	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Other Assets	223	256	275	354	349	534	534	424	361	463
Total Assets	334	413	461	572	678	897	979	975	881	942

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	19	65	15	168	-8.16	24	75	10	-8.40	-81
Cash from Investing Activity	-18	-49	-52	-74	-73	-104	-113	-135	-15	-4.31
Cash from Financing Activity	-0.94	-18	37	-95	81	80	38	125	24	94
Net Cash Flow	0.60	-2.51	-0.12	0.10	0.03	0.22	-0.08	-0.00	0.10	9.47

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Jul 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	66.75%	66.75%	66.75%	66.75%	66.75%	70.87%	70.87%	72.42%	72.42%	71.97%	71.97%	71.96%
FIIs	1.28%	1.25%	1.03%	0.53%	1.20%	0.25%	0.02%	0.02%	0.00%	0.04%	0.02%	0.01%
DIIs	9.74%	7.88%	3.38%	4.51%	5.41%	4.34%	4.26%	4.01%	4.01%	3.17%	3.34%	3.33%
Public	22.23%	24.11%	28.84%	28.21%	26.64%	24.54%	24.84%	23.55%	23.57%	24.82%	24.67%	24.69%
Total Shareholders	19,244	19,848	19,955	19,727	19,057	18,689	18,549	18,889	18,276	22,293	21,041	19,889

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Sentiment

Board Meeting

5 days ago

Astec Lifesciences Board Meeting on July 31, 2026

Astec Lifesciences Ltd will hold a Board meeting on 31/07/2026 to consider and approve standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.

Board Meeting

5 days ago

Astec Lifesciences Board Meeting on 31 July 2026

Astec Lifesciences Ltd: Board meeting scheduled for 31-07-2026 to consider and approve standalone and consolidated unaudited financial results for quarter ended 30-06-2026.

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Astec Lifesciences Ltd

Astec Lifesciences Ltd (ASTEC) is currently trading at 663.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Astec LifeSciences Ltd is primarily engaged in the manufacturing of agrochemicals and pharmaceutical intermediates, offering active ingredients, intermediates, and formulations mainly for crop protection and API manufacturers. The company expanded its operations significantly over the years, reaching an installed production capacity of 3150 MT, as of FY 2009-10. This expansion included acquiring new plots and establishing multiple manufacturing units. Astec LifeSciences has built strategic relationships with major multinationals like Syngenta and Nufarm, indicating strong integration into the global agrochemical supply chain. In 2015, Godrej Agrovet Limited acquired a major stake in the company, making Astec LifeSciences a subsidiary, which led to enhanced investment and growth opportunities. Recently, the company has focused on innovation, inaugurating the Adi Godrej Centre for Chemical Research and Development in 2023, indicating a drive towards advanced R&D capabilities.

Over the past 52 weeks, Astec Lifesciences Ltd has traded between a low of ₹512.35 and a high of ₹936.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Astec Lifesciences Ltd has a market capitalization of approximately 1,468.66. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Astec Lifesciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,468.66 Cr, Astec Lifesciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Astec Lifesciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Astec Lifesciences Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Astec Lifesciences Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Unlock more with professional

Peers

Price Chart Comparison